Significance of time-course changes of serum bone markers after parathyroidectomy in patients with uraemic hyperparathyroidism

Nephrology Dialysis Transplantation

Volumn 22, Issue 6, 2007, Pages 1645-1657

  Yajima, Aiji ^a   Inaba, Masaaki ^b   Ogawa, Yoshio ^c   Tominaga, Yoshihiro ^d   Tanizawa, Tatsuhiko ^e   Inou, Tsunamasa ^a   Otsubo, Osamu ^f  

^a Towa Hospital   (Japan)

^b OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d NAGOYA DAINI RED CROSS HOSPITAL   (Japan)

^e Tanizawa Orthopedic Clinic   (Japan)

^f Sangenjaya Hospital   (Japan)

Author keywords

Endocortical surface; Intracortical surface; Parathyroidectomy; Periosteal surface; Secondary hyperparathyroidism; Serum bone markers

Indexed keywords

22 OXACALCITRIOL; ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; ALFACALCIDOL; ALKALINE PHOSPHATASE; CALCITRIOL; CALCIUM; CALCIUM CARBONATE; DEOXYPYRIDINOLINE; GLUCONATE CALCIUM; OSTEOCALCIN; PARATHYROID HORMONE; PHOSPHORUS; PROCOLLAGEN C PROTEINASE;

ADULT; ARTICLE; BONE BIOPSY; BONE METABOLISM; CALCIUM BLOOD LEVEL; CANCELLOUS BONE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; CORTICAL BONE; DISEASE COURSE; DRUG TREATMENT FAILURE; FEMALE; HEMODIALYSIS; HUMAN; HUMAN TISSUE; HYPERPARATHYROIDISM; ILIAC BONE; MALE; MORPHOMETRICS; OSSIFICATION; OSTEOBLAST; OSTEOCLAST; OSTEOLYSIS; PARATHYROID HORMONE BLOOD LEVEL; PARATHYROIDECTOMY; PERIOSTEUM; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; UREMIA;

ADULT; AGED; BIOLOGICAL MARKERS; BONE AND BONES; FEMALE; HUMANS; HYPERPARATHYROIDISM; MALE; MIDDLE AGED; PARATHYROIDECTOMY; TIME FACTORS; UREMIA;

EID: 34447581286     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfl837     Document Type: Article

References (20)

1. Parfitt AM. Perspective: A structural approach to renal bone disease. J Bone Miner Res 1998; 13: 1213-1220
2. Han Z-H, Palnitkar S, Rao DS et al. Effects of ethnicity and age or menopause on the remodeling and turnover of iliac bone: Implications for mechanisms of bone loss. J Bone Miner Res 1997; 12: 498-508
3. Schober H-C, Han Z-H, Foldes AJ et al. Mineralized bone loss at different sites in dialysis patients: Implications for prevention. J Am Soc Nephrol 1998; 9: 1225-1233
4. Seeman E. Periosteal bone formation-A neglected determination of bone strength. N Engl J Med 2003; 349: 320-323
5. Yajima A, Ogawa Y, Takahashi HE et al. Changes of bone remodeling immediately after parathyroidectomy for secondary hyperparathyroidism. Am J Kidney Dis 2003; 42: 729-738
6. Yajima A, Tanaka K, Tominaga Y et al. Early changes of bone histology and circulating markers of bone turnover after parathyroidectomy in hemodialysis patients with severe hyperparathyroidism. Clin Nephrol 2001; 56: 27-34
7. Goodman WG, Glodin J, Kuizon BD et al. Coronary artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 2000; 342: 1478-1483
8. Abdelhadi M, Nordenström J. Bone mineral recovery after parathyroidectomy in patients with primary and renal hyperparathyroidism. J Clin Endocrinol Metab 1998; 83: 3845-3851
9. Balena R, Shih M-S, Parfitt AM. Bone resorption and formation on the periosteal envelope of the ilium: A histomorphometric study in healthy women. J Bone Miner Res 1992; 7: 1475-1482
10. Sherrard DJ, Hercz G, Pei Y et al. The spectrum of bone disease in end-stage renal failure: An evolving disorder. Kidney Int 1993; 43: 436-442
11. Malluche HH, Faugere MC. Renal bone disease 1990-an unmet challenge for the nephrologists. Kidney Int 1990; 38: 193-211
12. Salusky IB, Goodman WG, Kuizon BD et al. Similar predictive value of bone turnover using first- and second- generation immunometric PTH assays in pediatric patients treated with peritoneal dialysis. Kidney Int 2003; 63: 1801-1808
13. Urcňa P, Ferreira A, Kung VT et al. Serum pyridinoline as a specific marker of collagen breakdown and bone metabolism in hemodialysis patients. J Bone Miner Res 1995; 10: 932-939.
14. Melkko J, Niemi S, Risteli L et al. Radioimmunoassay of the carboxyterminal propeptide of human type I procollagen. Clin Chem 1990; 36: 1328-1332
15. Takahashi M, Kushida K, Nagano A et al. Comparison of the analytical and clinical performance characteristics of an N-MID versus an intact osteocalcin immunoradiometric assay. Clin Chim Acta 2000; 294: 67-76
16. Tanizawa T, Itoh A, Uchiyama T et al. Changes in cortical width with bone turnover in the three different endosteal envelopes of the ilium in post-menopausal osteoporosis. Bone 1999; 25: 493-499
17. Rauch F, Travers R, Glorieux FH. Cellular activity on the seven surfaces of iliac bone: A histomorphometric study in children and adolescents. J Bone Miner Res 2006; 21: 513-519
18. Clarke BL, Ebeling PR, Jones JD et al. Changes in quantitative bone histomorphometry in aging healthy men. J Clin Endocrinol Metab 1996; 81: 2264-2270
19. Suda T, Ueno Y, Fujii K, Shinki T. Vitamin D and bone. J Cell Biochem 2003; 88: 259-266
20. Kanatani M, Sugimoto T, Kanzawa M et al. High extracellular calcium inhibits osteoclast-like cell formation by directly acting on the calcium-sensing receptor existing in osteoclast precursor cells. Biochem Biophys Res Commun 1999; 261: 144-148